Antibiotic-eluting medical devices for various applications

Journal of Controlled Release

Volumn 130, Issue 3, 2008, Pages 202-215

  Zilberman, Meital ^a   Elsner, Jonathan J ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antibiotics; Drug release; Orthopedic implants; Periodontal devices; Wound dressings

Indexed keywords

ABS RESINS; BACTERIOLOGY; BIOCOMPATIBILITY; BIOPOLYMERS; BONE CEMENT; COMPOSITE FILMS; CONCENTRATION (PROCESS); NATURAL POLYMERS; TOXICITY;

DRUG RELEASE; ORTHOPEDIC IMPLANTS; PERIODONTAL DEVICES; WOUND DRESSINGS; WOUND HEALING PROCESSES;

ANTIBIOTICS;

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; BONE CEMENT; CEFAZOLIN; CEFOPERAZONE; CIPROFLOXACIN; COLISTIN; DOXYCYCLINE; DUOCID; ERYTHROMYCIN; FILLER; GENTAMICIN; METRONIDAZOLE; OFLOXACIN; POLYMER; RIFAMPICIN; SULPERAZONE; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BIOCOMPATIBILITY; BLOOD VESSEL GRAFT; DENTAL DEVICE; DEVICE INFECTION; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; MATERIAL COATING; MEDICAL INSTRUMENTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; WOUND DRESSING; WOUND HEALING;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BLOOD VESSEL PROSTHESIS; COATED MATERIALS, BIOCOMPATIBLE; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EQUIPMENT AND SUPPLIES; HUMANS; PERIODONTITIS; PROSTHESES AND IMPLANTS;

EID: 50949087869     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2008.05.020     Document Type: Review

References (137)

1. Sussman C., and Bates-Jensen B.M. Wound Care : A Collaborative Practice Manual for Physical Therapists and Nurses. 2nd ed. (2001), Aspen Publishers, Gaithersburg, Md 712 xxxii
2. Xu R.X., et al. Burns Regenerative Medicine and Therapy (2004) cited
3. Campton-Johnston S., and Wilson J. Infected wound management: advanced technologies, moisture-retentive dressings, and die-hard methods. Crit. Care Nurs. Q. 24 2 (2001) 64-77
4. Price J.S., et al. Controlled release of antibiotics from coated orthopedic implants. J. Biomed. Mater. Res. 30 3 (1996) 281-286
5. Ruszczak Z., and Friess W. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv. Drug Deliv. Rev. 55 12 (2003) 1679-1698
6. Gristina A.G. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 237 4822 (1987) 1588-1595
7. Springer B.D., et al. Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin. Orthop. Relat. Res. 427 (2004) 47-51
8. Zalavras C.G., Patzakis M.J., and Holtom P. Local antibiotic therapy in the treatment of open fractures and osteomyelitis. Clin. Orthop. Relat. Res. 427 (2004) 86-93
9. Stigter M., et al. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J. control. release 99 1 (2004) 127-137
10. Wu P., and Grainger D.W. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 27 11 (2006) 2450-2467
11. Gold H.S., and Moellering Jr. R.C. Antimicrobial-drug resistance. N. Engl. J. Med. 335 19 (1996) 1445-1453
12. Gransden W.R. Antibiotic resistance. Nosocomial gram-negative infection. J. Med. Microbiol. 46 6 (1997) 436-439
13. Hetrick E.M., and Schoenfisch M.H. Reducing implant-related infections: active release strategies. Chem. Soc. Rev. 35 9 (2006) 780-789
14. Smith A.W. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?. Adv. Drug Deliv. Rev. 57 10 (2005) 1539-1550
15. Buchholz H.W., and Engelbrecht H. Uber die Depotwirkung einiger Antibiotica bei Vermischung mit dem Kunstharz Palacos. Chirurg 41 11 (1970) 511-515
16. Levin P.D. The effectiveness of various antibiotics in methyl methacrylate. J. Bone Jt. Surg., Br. 57 2 (1975) 234-237
17. Bunetel L., et al. Release of gentamicin from acrylic bone cement. Clin. Pharmacol. 17 4 (1989) 291-297
18. DiMaio F.R., O'Halloran J.J., and Quale J.M. In vitro elution of ciprofloxacin from polymethylmethacrylate cement beads. J. Orthop. Res. 12 1 (1994) 79-82
19. Miclau T., Dahners L.E., and Lindsey R.W. In vitro pharmacokinetics of antibiotic release from locally implantable materials. J. Orthop. Res. 11 5 (1993) 627-632
20. Lu L., Garcia C.A., and Mikos A.G. In vitro degradation of thin poly(dl-lactic-co-glycolic acid) films. J. Biomed. Mater. Res. 46 2 (1999) 236-244
21. Garvin K.L., et al. Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. A canine model. J. Bone Jt. Surg., Am. 76 10 (1994) 1500-1506
22. Overbeck J.P., et al. Penetration of ciprofloxacin into bone: a new bioabsorbable implant. J. Invest. Surg. 8 3 (1995) 155-162
23. Nie L., et al. In vitro elution of ofloxacin from a bioabsorbable polymer. Acta Orthop. Scand. 66 4 (1995) 365-368
24. Ambrose C.G., et al. Antibiotic microspheres: preliminary testing for potential treatment of osteomyelitis. Clin. Orthop. Relat. Res. 415 (2003) 279-285
25. Rutledge B., et al. Treatment of osteomyelitis with local antibiotics delivered via bioabsorbable polymer. Clin. Orthop. Relat. Res. 411 (2003) 280-287
26. Hendricks K.J., et al. Elution characteristics of tobramycin from polycaprolactone in a rabbit model. Clin. Orthop. Relat. Res. 392 (2001) 418-426
27. Kanellakopoulou K., and Giamarellos-Bourboulis E.J. Carrier systems for the local delivery of antibiotics in bone infections. Drugs 59 6 (2000) 1223-1232
28. Jacob E., et al. Evaluation of biodegradable ampicillin anhydrate microcapsules for local treatment of experimental staphylococcal osteomyelitis. Clin. Orthop. Relat. Res. 267 (1991) 237-244
29. Nelson C.L., Hickmon S.G., and Skinner R.A. Treatment of experimental osteomyelitis by surgical debridement and the implantation of bioerodable, polyanhydride-gentamicin beads. J. Orthop. Res. 15 2 (1997) 249-255
30. Li L.C., Deng J., and Stephens D. Polyanhydride implant for antibiotic delivery-from the bench to the clinic. Adv. Drug Deliv. Rev. 54 7 (2002) 963-986
31. Yagmurlu M.F., et al. Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: in vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis. J. Biomed. Mater. Res. 46 4 (1999) 494-503
32. Rossi S., Azghani A.O., and Omri A. Antimicrobial efficacy of a new antibiotic-loaded poly(hydroxybutyric-co-hydroxyvaleric acid) controlled release system. J. Antimicrob. Chemother. 54 6 (2004) 1013-1018
33. Turesin F., Gursel I., and Hasirci V. Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release. J. Biomater. Sci., Polym. Ed. 12 2 (2001) 195-207
34. Lee J.E., et al. An infection-preventing bilayered collagen membrane containing antibiotic-loaded hyaluronan microparticles: physical and biological properties. Artif. Organs 26 7 (2002) 636-646
35. Park S.N., Kim J.K., and Suh H. Evaluation of antibiotic-loaded collagen-hyaluronic acid matrix as a skin substitute. Biomaterials 25 17 (2004) 3689-3698
36. Prabu P., et al. Preparation and drug release activity of scaffolds containing collagen and poly(caprolactone). J. Biomed. Mater. Res. A 79 1 (2006) 153-158
37. Shanmugasundaram N., et al. Design and delivery of silver sulfadiazine from alginate microspheres-impregnated collagen scaffold. J. Biomed. Mater. Res. B, Appl. Biomater. 77 2 (2006) 378-388
38. Sripriya R., Kumar M.S., and Sehgal P.K. Improved collagen bilayer dressing for the controlled release of drugs. J. Biomed. Mater. Res. B, Appl. Biomater. 70 2 (2004) 389-396
39. Aoyagi S., Onishi H., and Machida Y. Novel chitosan wound dressing loaded with minocycline for the treatment of severe burn wounds. Int. J. Pharm. 330 1-2 (2007) 138-145
40. Chung L.Y., et al. Biocompatibility of potential wound management products: fungal mycelia as a source of chitin/chitosan and their effect on the proliferation of human F1000 fibroblasts in culture. J. Biomed. Mater. Res. 28 4 (1994) 463-469
41. Mi F.L., et al. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J. Biomed. Mater. Res. 59 3 (2002) 438-449
42. Muzzarelli R., et al. Antimicrobial properties of N-carboxybutyl chitosan. Antimicrob. Agents Chemother. 34 10 (1990) 2019-2023
43. Rossi S., et al. Wound dressings based on chitosans and hyaluronic acid for the release of chlorhexidine diacetate in skin ulcer therapy. Pharm. Dev. Technol. 12 4 (2007) 415-422
44. Virk A., and Osmon D. Prosthetic joint infections. Curr. Treat. Options Infect. Dis. 3 (2001) 287-300
45. Segreti J. Prosthetic joint infections. Curr. Treat. Options Infect. Dis. 2 (2000) 200-207
46. An Y.H., and Friedman R.J. Prevention of sepsis in total joint arthroplasty. J. Hosp. Infect. 33 2 (1996) 93-108
47. Walenkamp G.H., Kleijn L.L., and de Leeuw M. Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. Acta Orthop. Scand. 69 5 (1998) 518-522
48. Wininger D.A., and Fass R.J. Antibiotic-impregnated cement and beads for orthopedic infections. Antimicrob. Agents Chemother. 40 12 (1996) 2675-2679
49. Webb J.C., and Spencer R.F. The role of polymethylmethacrylate bone cement in modern orthopaedic surgery. J. Bone Jt. Surg., Br. 89 7 (2007) 851-857
50. Jiranek W.A., Hanssen A.D., and Greenwald A.S. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J. Bone Jt. Surg., Am. 88 11 (2006) 2487-2500
51. Picknell B., Mizen L., and Sutherland R. Antibacterial activity of antibiotics in acrylic bone cement. J. Bone Jt. Surg., Br. 59 3 (1977) 302-307
52. Smilack J.D., Flittie W.H., and Williams Jr. T.W. Bone concentrations of antimicrobial agents after parenteral administration. Antimicrob. Agents Chemother. 9 1 (1976) 169-171
53. DiPisa J.A., Sih G.S., and Berman A.T. The temperature problem at the bone-acrylic cement interface of the total hip replacement. Clin. Orthop. Relat. Res. 121 (1976) 95-98
54. Webb J.C.J., et al. Very late release of gentamicin from bone cement in total hip arthroplasty (THA). J. Bone Jt. Surg., Br. 87-B (2005) (SUPP_I): 52-b-
55. Hanssen A.D. Prophylactic use of antibiotic bone cement: an emerging standard-in opposition.[comment]. J. Arthroplast. 19 4 Suppl 1 (2004) 73-77
56. Diez-Pena E., et al. Gentamicin sulphate release from a modified commercial acrylic surgical radiopaque bone cement. I. Influence of the gentamicin concentration on the release process mechanism. Chem. Pharm. Bull. 50 9 (2002) 1201-1208
57. Joseph T.N., Chen A.L., and Di Cesare P.E. Use of antibiotic-impregnated cement in total joint arthroplasty. J. Am. Acad. Orthop. Surg. 11 1 (2003) 38-47
58. Joosten U., et al. Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo. Biomaterials 25 18 (2004) 4287-4295
59. Armstrong M.S., et al. Mechanical characteristics of antibiotic-laden bone cement. Acta Orthop. Scand. 73 6 (2002) 688-690
60. Takechi M., et al. Effects of added antibiotics on the basic properties of anti-washout-type fast-setting calcium phosphate cement. J. Biomed. Mater. Res. 39 2 (1998) 308-316
61. Gbureck U., Probst J., and Thull R. Surface properties of calcium phosphate particles for self setting bone cements. Biomol. Eng. 19 2-6 (2002) 51-55
62. Schnieders J., et al. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 27 23 (2006) 4239-4249
63. Krasko M.Y., et al. Gentamicin extended release from an injectable polymeric implant. J. control. release 117 1 (2007) 90-96
64. Berger R.A., et al. Primary cementless acetabular reconstruction in patients younger than 50 years old. 7- to 11-year results. Clin. Orthop. Relat. Res. 344 (1997) 216-226
65. Raschke M.J., and Schmidmaier G. [Biological coating of implants in trauma and orthopedic surgery]. Unfallchirurg 107 8 (2004) 653-663
66. Wildemann B., et al. Short term in vivo biocompatibility testing of biodegradable poly(d,l-lactide)-growth factor coating for orthopaedic implants. Biomaterials 26 18 (2005) 4035-4040
67. DeJong E.S., et al. Antimicrobial efficacy of external fixator pins coated with a lipid stabilized hydroxyapatite/chlorhexidine complex to prevent pin tract infection in a goat model. J. Trauma 50 6 (2001) 1008-1014
68. Campbell A.A., et al. Development, characterization, and anti-microbial efficacy of hydroxyapatite-chlorhexidine coatings produced by surface-induced mineralization. J. Biomed. Mater. Res. 53 4 (2000) 400-407
69. Rauschmann M.A., et al. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials 26 15 (2005) 2677-2684
70. Teller M., et al. Release of gentamicin from bone regenerative materials: an in vitro study. J. Biomed. Mater. Res. B, Appl. Biomater. 81 1 (2007) 23-29
71. Stigter M., de Groot K., and Layrolle P. Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium. Biomaterials 23 20 (2002) 4143-4153
72. Chai F., et al. Antibacterial activation of hydroxyapatite (HA) with controlled porosity by different antibiotics. Biomol. Eng. (2007)
73. Alt V., et al. The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Biomaterials 27 26 (2006) 4627-4634
74. Gollwitzer H., et al. Antibacterial poly(d,l-lactic acid) coating of medical implants using a biodegradable drug delivery technology. J. Antimicrob. Chemother. 51 3 (2003) 585-591
75. Lucke M., et al. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 32 5 (2003) 521-531
76. Schmidmaier G., et al. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury 37 Suppl 2 (2006) S105-S112
77. Fulzele S.V., Satturwar P.M., and Dorle A.K. Novel biopolymers as implant matrix for the delivery of ciprofloxacin: biocompatibility, degradation, and in vitro antibiotic release. J. Pharm. Sci. 96 1 (2007) 132-144
78. Gursel I., et al. In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. Biomaterials 22 1 (2001) 73-80
79. Baro M., et al. In vitro-in vivo characterization of gentamicin bone implants. J. Control. Release 83 3 (2002) 353-364
80. Aviv M., Berdicevsky I., and Zilberman M. Gentamicin-loaded bioresorbable films for prevention of bacterial infections associated with orthopedic implants. J. Biomed. Mater. Res. A 83 1 (2007) 10-19
81. http://www.healthdigest.org/drugs/gentamicinsulfate.html.
82. Jones S.A., et al. Controlling wound bioburden with a novel silver-containing Hydrofiber dressing. Wound Repair Regen. 12 3 (2004) 288-294
83. Revathi G., Puri J., and Jain B.K. Bacteriology of burns. Burns 24 4 (1998) 347-349
84. Heggers J., et al. Therapeutic efficacy of three silver dressings in an infected animal model. J. Burn Care Rehabil. 26 1 (2005) 53-56
85. Fraser J.F., et al. An in vitro study of the anti-microbial efficacy of a 1% silver sulphadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. Burns 30 1 (2004) 35-41
86. Trop M. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J. Trauma 61 4 (2006) 1024
87. Suzuki Y., et al. A new drug delivery system with controlled release of antibiotic only in the presence of infection. J. Biomed. Mater. Res. 42 1 (1998) 112-116
88. Suzuki Y., et al. A novel wound dressing with an antibiotic delivery system stimulated by microbial infection. Asaio J. 43 5 (1997) M854-M857
89. Jürgens C., et al. Biodegradable films in trauma and orthopedic surgery. Euro. J. Trauma 2 (2006) 160-171
90. Varghese M.C., et al. Local environment of chronic wounds under synthetic dressings. Arch. Dermatol. 122 1 (1986) 52-57
91. Eisinger M., et al. Human epidermal cell cultures: growth and differentiation in the absence of differentiation in the absence of dermal components or medium supplements. Proc. Natl. Acad. Sci. U. S. A. 76 10 (1979) 5340-5344
92. Hutchinson F.G., and Furr B.J. Biodegradable polymers for the sustained release of peptides. Biochem. Soc. Trans. 13 2 (1985) 520-523
93. Katti D.S., et al. Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters. J. Biomed. Mater. Res. B, Appl. Biomater. 70 2 (2004) 286-296
94. Pruitt B.A., and Levine N.S. Characteristics and uses of biologic dressings and skin substitutes. Arch. Surg. 119 3 (1984) 312-322
95. Cairns B.A., et al. Skin replacements. The biotechnological quest for optimal wound closure. Arch. Surg. 128 11 (1993) 1246-1252
96. Maruguchi T., et al. A new skin equivalent: keratinocytes proliferated and differentiated on collagen sponge containing fibroblasts. Plast. Reconstr. Surg. 93 3 (1994) 537-544 discussion 545-6
97. Trafny E.A., Kowalska K., and Grzybowski J. Adhesion of Pseudomonas aeruginosa to collagen biomaterials: effect of amikacin and ciprofloxacin on the colonization and survival of the adherent organisms. J. Biomed. Mater. Res. 41 4 (1998) 593-599
98. Radu F.A., et al. Modeling of drug release from collagen matrices. J. Pharm. Sci. 91 4 (2002) 964-972
99. Taddeucci P., et al. An evaluation of Hyalofill-F plus compression bandaging in the treatment of chronic venous ulcers. J. Wound Care 13 5 (2004) 202-204
100. Colletta V., et al. A trial to assess the efficacy and tolerability of Hyalofill-F in non-healing venous leg ulcers. J. Wound Care 12 9 (2003) 357-360
101. M. Zilberman, et al., Gentamicin-eluting bioresorbable composite fibers for wound healing applications, J. Biomed. Mater. Res. A,. (in press) doi:10.1002/jbm.a.32013.
102. Foye W.O., Lemke T.L., and Williams D.A. Principles of Medicinal Chemistry. 3rd ed. Vol. 33 (1998), Lea & Febiger, Baltimore, MD 995
103. Southard G.L., and Godowski K.C. Subgingival controlled release of antimicrobial agents in the treatment of periodontal disease. Int. J. Antimicrob. Agents 9 4 (1998) 239-253
104. Kinane D.F. Local antimicrobial therapies in periodontal disease. Ann. R. Aust. Coll. Dent. Surg. 15 (2000) 57-60
105. Soskolne W.A. Subgingival delivery of therapeutic agents in the treatment of periodontal diseases. Crit. Rev. Oral Biol. Med. 8 2 (1997) 164-174
106. Goodson J.M., et al. Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets. J. Periodontol. 54 10 (1983) 575-579
107. Goodson J.M., et al. Periodontal disease treatment by local drug delivery. J. Periodontol. 56 5 (1985) 265-272
108. Coventry J., and Newman H.N. Experimental use of a slow release device employing chlorhexidine gluconate in areas of acute periodontal inflammation. J. Clin. Periodontol. 9 2 (1982) 129-133
109. Wan Yusof W.Z., et al. Subgingival metronidazole in dialysis tubing and subgingival chlorhexidine irrigation in the control of chronic inflammatory periodontal disease. J. Clin. Periodontol. 11 3 (1984) 166-175
110. Newman M.G., Kornman K.S., and Doherty F.M. A 6-month multi-center evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients: clinical results. J. Periodontol. 65 7 (1994) 685-691
111. Addy M., et al. The development and in vitro evaluation of acrylic strips and dialysis tubing for local drug delivery. J. Periodontol. 53 11 (1982) 693-699
112. Addy M., et al. Use of antimicrobial containing acrylic strips in the treatment of chronic periodontal disease. A three month follow-up study. J. Periodontol. 59 9 (1988) 557-564
113. Friedman M., and Golomb G. New sustained release dosage form of chlorhexidine for dental use. I. Development and kinetics of release. J. Periodontal. Res. 17 3 (1982) 323-328
114. Stabholz A., et al. The use of sustained release delivery of chlorhexidine for the maintenance of periodontal pockets: 2-year clinical trial. J. Periodontol. 62 7 (1991) 429-433
115. Golomb G., et al. Sustained release device containing metronidazole for periodontal use. J. Dent. Res. 63 9 (1984) 1149-1153
116. Elkayam R., et al. Sustained release device containing minocycline for local treatment of periodontal disease. J. control. release 7 3 (1988) 231-236
117. Higashi K., et al. Local ofloxacin delivery using a controlled-release insert (PT-01) in the human periodontal pocket. J. Periodontal. Res. 25 1 (1990) 1-5
118. Kimura S., et al. Topical chemotherapy in human periodontitis using a new controlled-release insert containing ofloxacin. I. Microbiological observation. J. Periodontal. Res. 26 1 (1991) 33-41
119. Deasy P.B., et al. Use of strips containing tetracycline hydrochloride or metronidazole for the treatment of advanced periodontal disease. J. Pharm. Pharmacol. 41 10 (1989) 694-699
120. Steinberg D., et al. A new degradable controlled release device for treatment of periodontal disease: in vitro release study. J. Periodontol. 61 7 (1990) 393-398
121. Norling T., et al. Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease. J. Clin. Periodontol. 19 9 Pt 2 (1992) 687-692
122. Shifrovitch, Y., et al., Metronidazole-Loaded Bioresorbable Films for Preventing Bacterial Infections During Gingival Healing. In preparation.
123. Soetevent C., et al. Vascular graft infection in aortoiliac and aortofemoral bypass surgery: clinical presentation, diagnostic strategies and results of surgical treatment. Neth. J. Med. 62 11 (2004) 446-452
124. Malassiney P., et al. Rifampicin loading of vascular grafts. J. Antimicrob. Chemother. 37 6 (1996) 1121-1129
125. Richardson R.L., et al. The outcome of antibiotic-soaked arterial grafts in guinea pig wounds contaminated with E. coli or S. aureus. J. Thorac. Cardiovasc. Surg. 59 5 (1970) 635-637
126. Blanchemain N., et al. Vascular PET prostheses surface modification with cyclodextrin coating: development of a new drug delivery system. Eur. J. Vasc. Endovasc. Surg. 29 6 (2005) 628-632
127. Chervu A., et al. Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system. J. Vasc. Surg. 14 4 (1991) 521-524 discussion 524-5
128. Moore W.S., et al. Development of an infection-resistant vascular prosthesis. Arch. Surg. 116 11 (1981) 1403-1407
129. Galdbart J.O., et al. Elution of six antibiotics bonded to polyethylene vascular grafts sealed with three proteins. J. Surg. Res. 66 2 (1996) 174-178
130. Goeau-Brissonniere O., et al. Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft. Ann. Vasc. Surg. 5 5 (1991) 408-412
131. Avramovic J.R., and Fletcher J.P. Rifampicin impregnation of a protein-sealed Dacron graft: an infection-resistant prosthetic vascular graft. Aust. N.Z. J. Surg. 61 6 (1991) 436-440
132. Strachan C.J., Newsom S.W., and Ashton T.R. The clinical use of an antibiotic-bonded graft. Eur. J. Vasc. Surg. 5 6 (1991) 627-632
133. Ginalska G., et al. Antibacterial activity of gentamicin-bonded gelatin-sealed polyethylene terephthalate vascular prostheses. Eur. J. Vasc. Endovasc. Surg. 29 4 (2005) 419-424
134. Ginalska G., Kowalczuk D., and Osinska M. Amikacin-loaded vascular prosthesis as an effective drug carrier. Int. J. Pharm. 339 1-2 (2007) 39-46
135. Blanchemain N., et al. Vascular prostheses with controlled release of antibiotics Part 1: Surface modification with cyclodextrins of PET prostheses. Biomol. Eng. 24 1 (2007) 149-153
136. A. Bryskier, Antimicrobial agents: antibacterials and antifungals, ASM Press, Washington, D.C., 2005 (various pagings).
137. S. Budavari, The Merck index: an encyclopedia of chemicals, drugs, and biologicals, 11th ed., Merck & Co., Rahway, N.J., 1989 (1 v.) (various pagings).